|
1
|
Kim RH and Armstrong AW: Nonmelanoma skin
cancer. Dermatol Clin. 30125–139. (ix)2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Singh CK, Ndiaye MA and Ahmad N:
Resveratrol and cancer: Challenges for clinical translation.
Biochim Biophys Acta. 1852:1178–1185. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
George J, Singh M, Srivastava AK, Bhui K,
Roy P, Chaturvedi PK and Shukla Y: Resveratrol and black tea
polyphenol combination synergistically suppress mouse skin tumors
growth by inhibition of activated MAPKs and p53. PLoS One.
6:e233952011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aziz MH, Reagan-Shaw S, Wu J, Longley BJ
and Ahmad N: Chemoprevention of skin cancer by grape constituent
resveratrol: Relevance to human disease? FASEB J. 19:1193–1195.
2005.PubMed/NCBI
|
|
5
|
Moore GE, Merrick SB, Woods LK and Arabasz
NM: A human squamous cell carcinoma cell line. Cancer Res.
35:2684–2688. 1975.PubMed/NCBI
|
|
6
|
Li Y, Liu ZL, Zhang KL, Chen XY, Kong QY,
Wu ML, Sun Y, Liu J and Li H: Methylation-associated silencing of
S100A4 expression in human epidermal cancers. Exp Dermatol.
18:842–848. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xia SL, Wu ML, Li H, Wang JH, Chen NN,
Chen XY, Kong QY, Sun Z and Liu J: CRABP-II- and FABP5-independent
responsiveness of human glioblastoma cells to all-trans retinoic
acid. Oncotarget. 6:5889–5902. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu ZL, Li Y, Kong QY, Zhan C, Wang Q,
Chen XY, Sun Y, Wen S, Tu CX, Liu J and Li H: Immunohistochemical
profiling of Wnt, NF-kappaB, Stat3 and Notch signaling in human
epidermal tumors. J Dermatol Sci. 52:133–136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Skalka N, Caspi M, Caspi E, Loh YP and
Rosin-Arbesfeld R: Carboxypeptidase E: A negative regulator of the
canonical Wnt signaling pathway. Oncogene. 32:2836–2847. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu ZQ, Brabletz T, Fearon E, Willis AL, Hu
CY, Li XY and Weiss SJ: Canonical Wnt suppressor, Axin2, promotes
colon carcinoma oncogenic activity. Proc Natl Acad Sci USA. 109:pp.
11312–11317. 2012; View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mikuła-Pietrasik J, Sosińska P and Książek
K: Resveratrol inhibits ovarian cancer cell adhesion to peritoneal
mesothelium in vitro by modulating the production of α5β1 integrins
and hyaluronic acid. Gynecol Oncol. 134:624–630. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Q, Li H, Wang XW, Wu DC, Chen XY and
Liu J: Resveratrol promotes differentiation and induces
Fas-independent apoptosis of human medulloblastoma cells. Neurosci
Lett. 351:83–86. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wen S, Li H, Wu ML, Fan SH, Wang Q, Shu
XH, Kong QY, Chen XY and Liu J: Inhibition of NF-κB signaling
commits resveratrol-treated medulloblastoma cells to apoptosis
without neuronal differentiation. J Neurooncol. 104:169–177. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Klaus A and Birchmeier W: Wnt signalling
and its impact on development and cancer. Nat Rev Cancer.
8:387–398. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Malanchi I, Peinado H, Kassen D, Hussenet
T, Metzger D, Chambon P, Huber M, Hohl D, Cano A, Birchmeier W and
Huelsken J: Cutaneous cancer stem cell maintenance is dependent on
beta-catenin signalling. Nature. 452:650–653. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bernkopf DB, Hadjihannas MV and Behrens J:
Negative-feedback regulation of the Wnt pathway by conductin/axin2
involves insensitivity to upstream signalling. J Cell Sci.
128:33–39. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bisson JA, Mills B, Helt JC Paul, Zwaka TP
and Cohen ED: Wnt5a and Wnt11 inhibit the canonical Wnt pathway and
promote cardiac progenitor development via the Caspase-dependent
degradation of AKT. Dev Biol. 398:80–96. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Abdelmaksoud-Dammak R, Miladi-Abdennadher
I, Saadallah-Kallel A, Khabir A, Sellami-Boudawara T, Frikha M,
Daoud J and Mokdad-Gargouri R: Downregulation of WIF-1 and Wnt5a in
patients with colorectal carcinoma: Clinical significance. Tumour
Biol. 35:7975–7982. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu LJ, Wu ML, Li H, Chen XY, Wang Q, Sun
Y, Kong QY and Liu J: Inhibition of STAT3 expression and signaling
in resveratrol-differentiated medulloblastoma cells. Neoplasia.
10:736–744. 2008. View Article : Google Scholar : PubMed/NCBI
|
